As part of the program, Ceramedix will join the New York City-based incubator JLABS. Ceramedix works to create antibody-based drugs that target diseases involving the microvasculature, according to a May 30 Ceramedix news release.
“As an early-stage company, we believe our residency will serve as a significant catalyst for our research and development work,” Charles Dimmler III, executive chair of Ceramedix, said in the release. “It will also provide our team with access to industry experts and key life science investors offered by the entrepreneurs and innovators ecosystem.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
